Radioprotectants to reduce the risk of radiation-induced carcinogenesis

References

• Antonadou D, Coliarakis N, Synodinou M, Athanassiou H, Kouveli A, Verigos C, Georgakopoulos G, Panoussaki K, Karageorgis P, Throuvalas N. 2001. Randomized phase III trial of radiation treatment +/− amifostine in patients with advanced-stage lung cancer. Int J Radiat Oncol, Biol, Phys 51:915–922.
   PubMed Web of Science ®Google Scholar
• BEIR VII. 2006. Health risks from exposure to low levels of ionizing radiation: BEIR VII Phase 2.
   Google Scholar
• Berenblum I, Burger M, Knyszynski A. 1974. Inhibition of radiation-induced lymphatic leukemia in C57BL mice by 19S alpha-2-globulin (alpha 2-MG) from human blood serum. Radiat Res 60:501–505.
   PubMedGoogle Scholar
• Berrington de Gonzalez A, Mahesh M, Kim KP, Bhargavan M, Lewis R, Mettler F, Land C. 2009. Projected cancer risks from computed tomographic scans performed in the United States in 2007. Arch Internal Med 169:2071–2077.
   PubMed Web of Science ®Google Scholar
• Borek C. 1981. Cellular transformation by radiation: Induction, promotion, and inhibition. J Supramolec Struct Cellul Biochem 16: 311–336.
   PubMedGoogle Scholar
• Brenner DJ, Elliston CD. 2004. Estimated radiation risks potentially associated with full-body CT screening. Radiology 232:735–738.
   PubMed Web of Science ®Google Scholar
• Brenner DJ, Hall EJ. 2007. Computed tomography – an increasing source of radiation exposure. New Eng J Med 357:2277–2284.
   PubMed Web of Science ®Google Scholar
• Brizel DM, Wasserman TH, Henke M, Strnad V, Rudat V, Monnier A, Eschwege F, Zhang J, Russell L, Oster W, et al. 2000. Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. J Clin Oncol 18:3339–3345.
   PubMed Web of Science ®Google Scholar
• Buc-Calderon P, Defresne MP, Barvais C, Roberfroid M. 1989. N-acyl dehydroalanines protect from radiation toxicity and inhibit radiation carcinogenesis in mice. Carcinogenesis 10:1641–1644.
   PubMed Web of Science ®Google Scholar
• Cipriano LE, Levesque BG, Zaric GS, Loftus EV Jr, Sandborn WJ. 2012. Cost-effectiveness of imaging strategies to reduce radiation-induced cancer risk in Crohn's disease. Inflamm Bowel Dis 18:1240–1248.
   PubMedGoogle Scholar
• Cohen BL. 2002. Cancer risk from low-level radiation. Am J Roentgenol 179:1137–1143.
   PubMed Web of Science ®Google Scholar
• Dange P, Sarma H, Pandey BN, Mishra KP. 2007. Radiation-induced incidence of thymic lymphoma in mice and its prevention by antioxidants. J Environ Pathol, Toxicol Oncol 26:273–279.
   PubMed Web of Science ®Google Scholar
• Desmond AN, O’Regan K, Curran C, McWilliams S, Fitzgerald T, Maher MM, Shanahan F. 2008. Crohn's disease: Factors associated with exposure to high levels of diagnostic radiation. Gut 57: 1524–1529.
   PubMed Web of Science ®Google Scholar
• Einstein AJ, Henzlova MJ, Rajagopalan S. 2007. Estimating risk of cancer associated with radiation exposure from 64-slice computed tomography coronary angiography. JAMA 298:317–323.
   PubMed Web of Science ®Google Scholar
• Emerit I, Oganesian N, Sarkisian T, Arutyunyan R, Pogosian A, Asrian K, Levy A, Cernjavski L. 1995. Clastogenic factors in the plasma of Chernobyl accident recovery workers: Anticlastogenic effect of Ginkgo biloba extract. Radiat Res 144:198–205.
   PubMed Web of Science ®Google Scholar
• Emerit I, Oganesian N, Arutyunian R, Pogossian A, Sarkisian T, Cernjavski L, Levy A, Feingold J. 1997. Oxidative stress-related clastogenic factors in plasma from Chernobyl liquidators: Protective effects of antioxidant plant phenols, vitamins and oligoelements. Mutat Res 377:239–246.
   PubMed Web of Science ®Google Scholar
• Faguet GB, Reichard SM, Welter DA. 1984. Radiation-induced clastogenic plasma factors. Cancer Genet Cytogenet 12:73–83.
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration (FDA). 2002. Evidence needed to demonstrate effectiveness of new drugs when human efficacy studies are not ethical or feasible. In: Adminstration FaD ed. No. 105. Vol. 67 ed.
   Google Scholar
• Floersheim GL, Christ A, Koenig R, Racine C, Gudat F. 1992. Radiation-induced lymphoid tumors and radiation lethality are inhibited by combined treatment with small doses of zinc aspartate and WR 2721. Int J Cancer 52:604–608.
   PubMed Web of Science ®Google Scholar
• Gaziev AI, Podlutsky A, Panfilov BM, Bradbury R. 1995. Dietary supplements of antioxidants reduce hprt mutant frequency in splenocytes of aging mice. Mutat Res 338:77–86.
   PubMedGoogle Scholar
• Gaziev AI, Sologub GR, Fomenko LA, Zaichkina SI, Kosyakova NI, Bradbury RJ. 1996. Effect of vitamin-antioxidant micronutrients on the frequency of spontaneous and in vitro gamma-ray- induced micronuclei in lymphocytes of donors: The age factor. Carcinogenesis 17:493–499.
   PubMed Web of Science ®Google Scholar
• Gosling O, Loader R, Venables P, Roobottom C, Rowles N, Bellenger N, Morgan-Hughes G. 2010. A comparison of radiation doses between state-of-the-art multislice CT coronary angiography with iterative reconstruction, multislice CT coronary angiography with standard filtered back-projection and invasive diagnostic coronary angiography. Heart 96:922–926.
   PubMed Web of Science ®Google Scholar
• Grdina DJ, Carnes BA, Grahn D, Sigdestad CP. 1991. Protection against late effects of radiation by S-2-(3-aminopropylamino)- ethylphosphorothioic acid. Cancer Res 51:4125–4130.
   PubMed Web of Science ®Google Scholar
• Grdina DJ, Kataoka Y, Basic I, Perrin J. 1992. The radioprotector WR-2721 reduces neutron-induced mutations at the hypoxanthine-guanine phosphoribosyl transferase locus in mouse splenocytes when administered prior to or following irradiation. Carcinogenesis 13:811–814.
   PubMed Web of Science ®Google Scholar
• Grdina DJ, Murley JS, Kataoka Y, Epperly W. 2002. Relationships between cytoprotection and mutation prevention by WR-1065. Milit Med 167:51–53.
   PubMedGoogle Scholar
• Grdina DJ, Nagy B, Hill CK, Wells RL, Peraino C. 1985. The radioprotector WR1065 reduces radiation-induced mutations at the hypoxanthine-guanine phosphoribosyl transferase locus in V79 cells. Carcinogenesis 6:929–931.
   PubMed Web of Science ®Google Scholar
• Grdina DJ, Shigematsu N, Dale P, Newton GL, Aguilera JA, Fahey RC. 1995. Thiol and disulfide metabolites of the radiation protector and potential chemopreventive agent WR-2721 are linked to both its anti-cytotoxic and anti-mutagenic mechanisms of action. Carcinogenesis 16:767–774.
   PubMedGoogle Scholar
• Gross L. 1988. Inhibition of the development of tumors or leukemia in mice and rats after reduction of food intake. Possible implications for humans. Cancer 62:1463–1465.
   PubMed Web of Science ®Google Scholar
• Gross L, Dreyfuss Y. 1990. Prevention of spontaneous and radiation-induced tumors in rats by reduction of food intake. Proc Nat Acad Sci USA 87:6795–6797.
   PubMed Web of Science ®Google Scholar
• Hall EJ, Giaccia A. 2012. Radiobiology for the radiologist. 7th ed. Philadelphia, PA, Lippincott Williams & Wilkins.
   Google Scholar
• Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS, Deroo B, Rosner B, Speizer FE, Pollak M. 1998. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 351:1393–1396.
   PubMed Web of Science ®Google Scholar
• Hanson KD, Shichiri M, Follansbee MR, Sedivy JM. 1994. Effects of c-myc expression on cell cycle progression. Molec Cell Biol 14: 5748–5755.
   PubMedGoogle Scholar
• Inano H, Onoda M. 2002. Radioprotective action of curcumin extracted from Curcuma longa LINN: Inhibitory effect on formation of urinary 8-hydroxy-2′-deoxyguanosine, tumorigenesis, but not mortality, induced by gamma-ray irradiation. Int J Radiat Oncol, Biol, Phys 53:735–743.
   PubMed Web of Science ®Google Scholar
• Inano H, Onoda M, Suzuki K, Kobayashi H, Wakabayashi K. 2000a. Prevention of radiation-induced mammary tumours in rats by combined use of WR-2721 and tamoxifen. Int J Radiat Biol 76:1113–1120.
   PubMed Web of Science ®Google Scholar
• Inano H, Onoda M, Suzuki K, Kobayashi H, Wakabayashi K. 2000b. Inhibitory effects of WR-2721 and cysteamine on tumor initiation in mammary glands of pregnant rats by radiation. Radiat Res 153: 68–74.
   PubMed Web of Science ®Google Scholar
• Jellema AP, Slotman BJ, Muller MJ, Leemans CR, Smeele LE, Hoekman K, Aaronson NK, Langendijk JA. 2006. Radiotherapy alone, versus radiotherapy with amifostine 3 times weekly, versus radiotherapy with amifostine 5 times weekly: A prospective randomized study in squamous cell head and neck cancer. Cancer 107:544–553.
   PubMed Web of Science ®Google Scholar
• Kagimoto O, Naganuma A, Imura N, Toge T, Niwa O, Yokoro K. 1991. Effect of the administration of bismuth nitrate on radiogenic thymoma induction in mice. J Radiat Res 32:417–428.
   PubMed Web of Science ®Google Scholar
• Kambadakone AR, Prakash P, Hahn PF, Sahani DV. 2010. Low-dose CT examinations in Crohn's disease: Impact on image quality, diagnostic performance, and radiation dose. Am J Roentgenol 195:78–88.
   PubMed Web of Science ®Google Scholar
• Kanal KM, Stewart BK, Kolokythas O, Shuman WP. 2007. Impact of operator-selected image noise index and reconstruction slice thickness on patient radiation dose in 64-MDCT. Am J Roentgenol 189:219–225.
   PubMed Web of Science ®Google Scholar
• Kempf SR, Port RE, Ivankovic S. 1994. Anticarcinogenic effect of tetrachlorodecaoxide after total-body gamma irradiation in rats. Radiat Res 139:226–231.
   PubMedGoogle Scholar
• Kligerman MM, Glover DJ, Turrisi AT, Norfleet AL, Yuhas JM, Coia LR, Simone C, Glick JH, Goodman RL. 1984. Toxicity of WR-2721 administered in single and multiple doses. Int J Radiat Oncol, Biol, Phys 10:1773–1776.
   PubMed Web of Science ®Google Scholar
• Little JB. 1981. Influence of noncarcinogenic secondary factors on radiation carcinogenesis. Radiat Res 87:240–250.
   PubMed Web of Science ®Google Scholar
• Meer AB, Basu PA, Baker LC, Atlas SW. 2012. Exposure to ionizing radiation and estimate of secondary cancers in the era of high-speed CT scanning: Projections from the Medicare population. J Am Coll Radiol 9:245–250.
   PubMedGoogle Scholar
• Mezrich R. 2008. Are CT scans carcinogenic?. J Am Coll Radiol 5: 691–693.
   PubMedGoogle Scholar
• Milas L, Hunter N, Stephens LC, Peters LJ. 1984. Inhibition of radiation carcinogenesis in mice by S-2-(3-aminopropylamino)-ethylphosphorothioic acid. Cancer Res 44:5567–5569.
   PubMed Web of Science ®Google Scholar
• Milas L, Nishiguchi I, Hunter N, Murray D, Fleck R, Ito H, Travis E. 1992. Radiation protection against early and late effects of ionizing irradiation by the prostaglandin inhibitor indomethacin. Adv Space Res 12:265–271.
   PubMedGoogle Scholar
• Mitchell JB, Anver MR, Sowers AL, Rosenberg PS, Figueroa M, Thetford A, Krishna MC, Albert PS, Cook JA. 2012. The antioxidant tempol reduces carcinogenesis and enhances survival in mice when administered after nonlethal total body radiation. Cancer Res 72:4846–4855.
   PubMed Web of Science ®Google Scholar
• Movsas B, Scott C, Langer C, Werner-Wasik M, Nicolaou N, Komaki R, Machtay M, Smith C, Axelrod R, Sarna L, et al. 2005. Randomized trial of amifostine in locally advanced non-small- cell lung cancer patients receiving chemotherapy and hyperfractionated radiation: Radiation therapy oncology group trial 98–01. J Clin Oncol 23:2145–2154.
   PubMed Web of Science ®Google Scholar
• Murley JS, Kataoka Y, Hallahan DE, Roberts JC, Grdina DJ. 2001. Activation of NFkappaB and MnSOD gene expression by free radical scavengers in human microvascular endothelial cells. Free Rad Biol Med 30:1426–1439.
   PubMed Web of Science ®Google Scholar
• Narisawa T, Sato M, Tani M, Kudo T, Takahashi T, Goto A. 1981. Inhibition of development of methylnitrosourea-induced rat colon tumors by indomethacin treatment. Cancer Res 41:1954–1957.
   PubMed Web of Science ®Google Scholar
• National Comprehensive Cancer Network. 2012. NCCN Clinical Practice Gidelines in Oncology: Testicular Cancerhttp://www.nccn.org/professionals/physician_gls/pdf/testicular.pdf
   Google Scholar
• Paterson A, Frush DP. 2007. Dose reduction in paediatric MDCT: General principles. Clin Radiol 62:507–517.
   PubMedGoogle Scholar
• Pearce MS, Salotti JA, Little MP, McHugh K, Lee C, Kim KP, Howe NL, Ronckers CM, Rajaraman P, Craft AW, et al. 2012. Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: A retrospective cohort study. The Lancet 380: 499–505.
   PubMed Web of Science ®Google Scholar
• Petridou E, Dessypris N, Spanos E, Mantzoros C, Skalkidou A, Kalmanti M, Koliouskas D, Kosmidis H, Panagiotou JP, Piperopolou F, et al. 1999. Insulin-like growth factor-I and binding protein-3 in relation to childhood leukaemia. Int J Cancer 80:494–496.
   PubMedGoogle Scholar
• Pollak MN, Schernhammer ES, Hankinson SE. 2004. Insulin-like growth factors and neoplasia. Nature Rev: Cancer 4:505–518.
   PubMed Web of Science ®Google Scholar
• Pollycove M. 1998. Nonlinearity of radiation health effects. Environ Health Perspect 106(Suppl. 1):363–368.
   PubMedGoogle Scholar
• Preston DL, Kusumi S, Tomonaga M, Izumi S, Ron E, Kuramoto A, Kamada N, Dohy H, Matsuo T, Matsui T, et al. 1994. Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950–1987. Radiat Res 137:S68–97.
   PubMed Web of Science ®Google Scholar
• Purdie JW, Inhaber ER, Schneider H, Labelle JL. 1983. Interaction of cultured mammalian cells with WR-2721 and its thiol, WR-1065: Implications for mechanisms of radioprotection. Int J Radiat Biol Rel Stud Phys, Chem Med 43:517–527.
   PubMed Web of Science ®Google Scholar
• Reddy BS, Nayini J, Tokumo K, Rigotty J, Zang E, Kelloff G. 1990. Chemoprevention of colon carcinogenesis by concurrent administration of piroxicam, a nonsteroidal antiinflammatory drug with D,L-alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor, in diet. Cancer Res 50:2562–2568.
   PubMed Web of Science ®Google Scholar
• Shen H, Chen ZJ, Zilfou JT, Hopper E, Murphy M, Tew KD. 2001. Binding of the aminothiol WR-1065 to transcription factors influences cellular response to anticancer drugs. J Pharmacol Experim Therapeut 297:1067–1073.
   PubMed Web of Science ®Google Scholar
• Shibuya K, Nishimura N, Suzuki JS, Tohyama C, Naganuma A, Satoh M. 2008. Role of metallothionein as a protective factor against radiation carcinogenesis. J Toxicolog Sci 33:651–655.
   PubMed Web of Science ®Google Scholar
• Sun Z, Ng KH. 2010. Multislice CT angiography in cardiac imaging. Part III: Radiation risk and dose reduction. Singapore Med J 51:374–380.
   PubMedGoogle Scholar
• Suzuki K, Ishii-Ohba H, Yamanouchi H, Wakabayashi K, Takahashi M, Inano H. 1994. Susceptibility of lactating rat mammary glands to gamma-ray-irradiation-induced tumorigenesis. Int J Cancer 56:413–417.
   PubMedGoogle Scholar
• Tamm EP, Rong XJ, Cody DD, Ernst RD, Fitzgerald NE, Kundra V. 2011. Quality initiatives: CT radiation dose reduction: How to implement change without sacrificing diagnostic quality. Radiographics 31:1823–1832.
   PubMedGoogle Scholar
• Uma Devi P, Satyamitra M. 2004. Protection against prenatal irradiation-induced genomic instability and its consequences in adult mice by Ocimum, flavonoids, orientin and vicenin. Int J Radiat Biol 80:653–662.
   PubMed Web of Science ®Google Scholar
• Upton AC, Wolff FF, Furth J, Kimball AW. 1958. A comparison of the induction of myeloid and lymphoid leukemias in x-radiated RF mice. Cancer Res 18:842–848.
   PubMed Web of Science ®Google Scholar
• Weustink AC, Mollet NR, Neefjes LA, van Straten M, Neoh E, Kyrzopoulos S, Meijboom BW, van Mieghem C, Cademartiri F, de Feyter PJ, et al. 2009. Preserved diagnostic performance of dual-source CT coronary angiography with reduced radiation exposure and cancer risk. Radiology 252:53–60.
   PubMedGoogle Scholar
• Wu MH, Chou YC, Chou WY, Hsu GC, Chu CH, Yu CP, Yu JC, Sun CA. 2009. Circulating levels of leptin, adiposity and breast cancer risk. Br J Cancer 100:578–582.
   PubMed Web of Science ®Google Scholar
• Yoshida K, Inoue T, Nojima K, Hirabayashi Y, Sado T. 1997. Calorie restriction reduces the incidence of myeloid leukemia induced by a single whole-body radiation in C3H/He mice. Proc Nat Acad Sci USA 94:2615–2619.
   PubMed Web of Science ®Google Scholar
• Yoshida K, Hirabayashi Y, Watanabe F, Sado T, Inoue T. 2006. Caloric restriction prevents radiation-induced myeloid leukemia in C3H/HeMs mice and inversely increases incidence of tumor-free death: Implications in changes in number of hemopoietic progenitor cells. Experim Hematol 34:274–283.
   PubMed Web of Science ®Google Scholar
• Zhao L, Zhou C, Zhang J, Gao F, Li B, Chuai Y, Liu C, Cai J 2011. Hydrogen protects mice from radiation induced thymic lymphoma in BALB/c mice. Int J Biologic Sci 7:297–300.
   PubMed Web of Science ®Google Scholar